Rituximab—a B cell targeted therapy in systemic lupus erythematosus: where do we stand?-Reference-Cited by-同舟云学术

Rituximab—a B cell targeted therapy in systemic lupus erythematosus: where do we stand?

Published:2022-02-22 Issue:5 Volume:61 Page:1752-1755
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Piantoni Silvia¹^ORCID,Korsten Peter²^ORCID

Affiliation:

1. Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy

2. Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany

Funder

Abbvie

Astra Zeneca

Bristol-Myers-Squibb

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac095/42686889/keac095.pdf

Reference15 articles.

1. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus;Fanouriakis;Ann Rheum Dis,2019

2. Can we predict if patients with SLE will require more than one cycle of rituximab?;Fernández González;Rheumatology

3. Off-label use of rituximab for systemic lupus erythematosus in Europe;Rydén-Aulin;Lupus Sci Med,2016

4. B cells as therapeutic targets in SLE;Sanz;Nat Rev Rheumatol,2010

5. Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus;Wincup;Ann Rheum Dis,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium;Journal of Clinical Medicine;2022-10-12

2. Systemic lupus erythematosus: history and modernity;Rheumatology Science and Practice;2022-09-06